Image source: The Motley Fool. PolyPid (NASDAQ:PYPD) is nearing completion of its rolling NDA for D-PLEX100, with imminent clinical module submission poised to trigger the FDA review process. The ...

PolyPid said it has entered a key regulatory transition for D-PLEX100, with its rolling NDA submission to the FDA underway and the remaining clinical module expected to be filed imminently. The ...

Nahda Nabiilah is a writer and editor from Indonesia. She has always loved writing and playing games, so one day she decided to combine the two. Most of the time, writing gaming guides is a blast for ...

SOUTH SAN FRANCISCO, Calif., April 30, 2026 /PRNewswire/ -- FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise medication decisions, ...

This new platform bridges the gap between routine patient care and clinical research, creating a single, comprehensive wound data backbone for sponsors and research sites. BOCA RATON, FL / ACCESS ...

Good afternoon, and welcome to the Sangamo Therapeutics Fourth Quarter and Full Year 2025 Teleconference Call. Please be advised that today's conference is being recorded. I would now like to turn the ...

India added 119 GW of solar module capacity and over 9 GW of cell capacity in 2025, bringing total capacities to about 210 GW and 27 GW, respectively, according to Mercom India. Growth was driven by ...

New eTMF module integrates with Enlighten Clinical Solutions’ platform to support inspection-ready clinical trial documentation and execution. ATLANTA, GA, UNITED ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

RUMSON, New Jersey (WABC) -- A Rumson, New Jersey, psychiatric professional was losing her own mind when she kept getting charged monthly for a medical billing service she never used. After several ...

1-Year Data from Endospan's NEXUS TRIOMPHE IDE Trial Demonstrate High Patient Survival with Low Morbidity 2-Year Data from the AMDS PERSEVERE IDE Trial Further Demonstrate the Persistent Clinical ...